Temporin-G

General Information


DRACP ID  DRACP01049

Peptide Name   Temporin-G

Sequence  FFPVIGRILNGIL

Sequence Length  13

UniProt ID  Not available

PubChem CID  Not available

Origin  Rana temporaria

Type  Native peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
A549 Lung adenocarcinoma Carcinoma 50% Cytotoxicity=73µM MTT assay 24h 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antiviral



Structure Information


PDB ID  Not available

Predicted Structure  DRACP01049

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C72H115N17O15

Absent amino acids  ACDEHKMQSTWY

Common amino acids  I

Mass  167304

Pl  10.55

Basic residues  1

Acidic residues  0

Hydrophobic residues  8

Net charge  1

Boman Index  1492

Hydrophobicity  157.69

Aliphatic Index  172.31

Half Life 
  Mammalian:
  Yeast:
  E.coli:

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  3

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 33538061

Title  Temporin G, an amphibian antimicrobial peptide against influenza and parainfluenza respiratory viruses: Insights into biological activity and mechanism of action

Doi 10.1096/fj.202001885RR

Year  2021

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.